Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.35% | $44.30M | €458.08B | 67.61% | 76 Outperform | |
| AstraZeneca | 2.72% | $35.99M | $324.77B | 32.79% | 80 Outperform | |
| UniCredit SpA | 1.86% | $24.58M | €113.96B | 78.69% | 75 Outperform | |
| Rolls-Royce Holdings | 1.82% | $24.08M | £109.32B | 121.53% | 71 Outperform | |
| Renesas Electronics | 1.63% | $21.58M | ¥5.30T | 15.22% | 64 Neutral | |
| Roche Holding AG | 1.59% | $21.07M | CHF294.92B | 46.36% | 73 Outperform | |
| Unilever | 1.40% | $18.49M | £118.04B | 7.61% | 72 Outperform | |
| Deutsche Telekom | 1.25% | $16.59M | €163.15B | -6.15% | 67 Neutral | |
| Siemens | 1.24% | $16.39M | €183.95B | 8.14% | 74 Outperform | |
| Mitsubishi UFJ Financial Group | 1.23% | $16.33M | ¥32.17T | 40.45% | 76 Outperform |